Metastatic Esophageal Adenocarcinoma
10 clinical trials · Condition
◉ Watch Metastatic Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca (NCT04921904) | Baylor Research Institute | 2021-06-11 |
| Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937) | National Cancer Institute (NCI) | 2021-04-09 |
| Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body (NCT04248452) | ECOG-ACRIN Cancer Research Group | 2020-05-26 |
| Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT01142388) | National Cancer Institute (NCI) | 2010-09-21 |
Track Metastatic Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.